60
Participants
Start Date
March 15, 2014
Primary Completion Date
March 9, 2017
Study Completion Date
February 9, 2018
Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells
Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells was administered intravenously over approximately 60-80 minutes.
Plasma-Lyte A
Plasma-Lyte A placebo was administered intravenously over approximately 60-80 minutes.
University of Pittsburgh, Pittsburgh
Ohio State University, Columbus
University of Minnesota Medical Center, Saint Paul
University of California San Francisco, San Francisco
Stanford University, Stanford
Massachusetts General Hospital, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Massachusetts General Hospital
OTHER
Stanford University
OTHER
University of Pittsburgh
OTHER
University of Minnesota
OTHER
Ohio State University
OTHER
Michael A. Matthay
OTHER